Companies unveil new drug plans

Posted 7 June 2024 AM

Three companies have begun the process to gain government subsidy for their cancer drugs ahead of TGA approval, an update from the Medical Services Advisory Committee (MSAC) shows.

Certain tests to determine eligibility for Taiho Pharma's Lytgobi, A Menarini's Orserdu, and Roche's inavolisib on the PBS have been scheduled for MSAC's PICO Advisory Sub Committee's (PASC) meeting in August 2024.

To see the whole article, please login